Clinical Trials Logo

Peptic Ulcer clinical trials

View clinical trials related to Peptic Ulcer.

Filter by:

NCT ID: NCT03562026 Completed - Clinical trials for Peptic Ulcer, Gastroesophageal Reflux

S-CEI of Nexium in Paediatric Patients

Start date: June 28, 2018
Phase:
Study type: Observational

To capture safety and efficacy when Nexium are administered to pediatric patients in clinical practice after launch

NCT ID: NCT03551262 Recruiting - Clinical trials for Bleeding Peptic Ulcer

Over-the-scope Clip Versus Through-the-scope Clip for Endoscopic Hemostasis of High Risk Bleeding Peptic Ulcers

OTSCvsTTS
Start date: October 26, 2018
Phase: N/A
Study type: Interventional

To compare in a multicenter, prospective, randomized, controlled trial the efficacy and safety of OTSC versus TTS clip for first-line hemostasis of high risk bleeding peptic ulcers

NCT ID: NCT03469167 Completed - Clinical trials for Peptic Ulcer Bleeding

Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding

CEGP003
Start date: October 15, 2014
Phase: N/A
Study type: Interventional

This is a prospective, single-blinded, randomized study to evaluate the efficacy and safety of CEGP003 in patients with acute peptic ulcers bleeding, compared to endoscopic epinephrine injection therapy.

NCT ID: NCT03367897 Completed - Peptic Ulcer Clinical Trials

Bleeding Ulcer and Erosions Study "BLUE Study"

BLUE
Start date: March 2015
Phase:
Study type: Observational [Patient Registry]

A prospective study of bleeding peptic ulcers and/or erosions in the upper gastrointestinal tract - risk-medication, presence of Helicobacter pylori, treatment and outcome.

NCT ID: NCT03362281 Completed - Clinical trials for Peptic Ulcer Hemorrhage

Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Start date: October 2014
Phase: Phase 3
Study type: Interventional

The purpose of this phase study is to confirm the efficacy and safety by compare ilaprazole and omeprazole in the treatment and prevention of peptic ulcer bleeding. Patients with endoscopically diagnosed peptic ulcer bleeding were enrolled in a multi-center, stratified randomized, non-inferiority test, double-blind, parallel and positive-controlled trial. They were randomly assigned into two groups, ilaprazole and omeprazole, to be treated for up to 30 days. The primary endpoint was the hemostasis rate at the end of 72 hours. Secondary end points include ulcer staging changes within 72 hours, effective rate of hemostasis, hemostasis duration, average blood transfusion and rebleeding rate, etc.

NCT ID: NCT03362268 Completed - Clinical trials for Peptic Ulcer Hemorrhage

IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Start date: February 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of ilaprazole and omeprazole in the treatment and prevention of peptic ulcer bleeding. Patients with endoscopically diagnosed peptic ulcer bleeding were enrolled in a randomized, double-blind, parallel and positive-controlled trial. They were randomly assigned into two groups, ilaprazole and omeprazole, to be treated for up to 30 days and be seen at day 3, 4, 7, 14 and 30. The primary endpoint was the hemostasis rate (hemostatic groups with endoscopy check ) and re-bleeding rate ( bleeding groups with endoscopy check) within 72 hours. Secondary end points include effective rate of hemostasis, mean volume of blood transfusion, the length of stay and re-bleeding rate, etc.

NCT ID: NCT03320538 Recruiting - Clinical trials for Peptic Ulcer Disease

Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases

Start date: July 10, 2017
Phase: N/A
Study type: Interventional

This trial aims to determine whether Jiangzhong Hou Gu® Mi Xi™ is an effective intervention to improve symptoms and indicators in patients with spleen qi deficiency and peptic ulcer diseases.

NCT ID: NCT03228095 Enrolling by invitation - Colorectal Cancer Clinical Trials

Volatiles in Breath and Headspace Analysis - Diagnostic Markers

Volatolome
Start date: July 24, 2017
Phase:
Study type: Observational

Detection of Volatile Organic Compounds (VOC) directly from tissue by headspace analysis (skin, surgery material, other tissue) and exhaled breath is feasible using affordable user-friendly novel nano-chemo sensors that can accurately be used for screening and monitoring purpose

NCT ID: NCT03163680 Completed - Clinical trials for Peptic Ulcer Hemorrhage

Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers

Start date: January 2012
Phase:
Study type: Observational

Determining the efficacy of low dose of PPI in management acute peptic ulcer bleeding

NCT ID: NCT03160911 Completed - Ulcer Bleeding Clinical Trials

The Use of Over-the-scope-clip for Prevention of Rebleeding in High Risk Peptic Ulcers

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

Non-variceal acute gastrointestinal bleeding is a common and potentially life-threatening problem. The conventional treatment of this condition is for esophagogastroduodenoscopy (OGD) for haemostasis. Treatment methods include heater probe, clipping and injection of adrenaline. Recently, a new device called the Over-the-scope clip (OTSC) has been device to treat perforations and bleeding in the gastrointestinal tract. Therefore, the aim of the study is to compare between the treatment outcomes between OTSC and conventional endoscopic haemostatic methods in ulcers that are of high risk for rebleeding.